ELI LILLY & Co (LLY) stock
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 19/3024% above fair value
$1443.50+16.22 (+1.14%)
Close on Nov 13, 2026Market cap $1.36TP/E 46.9Yield 0.43%
Eli Lilly statistics
97 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 3, 2027 (estimated, before the open)
- Last ex-dividend date
- Aug 14, 2026
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 110.29
- 2.22
- P/OCF Ratio
- 44.31
- 12.99
Enterprise valuationIndustry
- EV / Sales
- 16.22
- 2.57
Share statisticsIndustry
- Shares Change (YoY)
- -0.59%
- 10.8%
- Float
- 843M
- 49M
- Shares Held by Insiders
- 10.4%
- 11.7%
- Shares Held by Institutions
- 83.8%
- 56.4%
Short sellingIndustry
- Short Interest
- 7M
- –
- Short Interest Change
- 3.64%
- -0.80%
- Short % of Float
- 0.86%
- 9.01%
- Short % of Shares Outstanding
- 0.77%
- 6.30%
- Days to Cover
- 2.66
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $1460.00
- –
- 52-Week Low
- $850.51
- –
- 20-Day Moving Average
- $1356.24
- –
- 50-Day Moving Average
- $1241.08
- –
- 200-Day Moving Average
- $1109.32
- –
- Average True Range (14)
- $44.31
- –
- Price Change (1 Week)
- 6.61%
- -1.15%
- Price Change (1 Month)
- 15.3%
- -4.87%
- Price Change (3 Months)
- 22.0%
- -21.0%
- Price Change (6 Months)
- 43.6%
- -20.6%
- Price Change (YTD)
- 34.3%
- -23.6%
- Price Change (1 Year)
- 41.8%
- -22.4%
- Price Change (3 Years)
- 136.3%
- -29.5%
- Price Change (5 Years)
- 455.9%
- -77.9%
- Price Change (10 Years)
- 1774.2%
- -65.4%
- Average Volume (10 Days)
- 3M
- –
- Average Volume (20 Days)
- 3M
- –
- Average Volume (90 Days)
- 3M
- –
- Relative Volume
- 0.81
- 0.70
- Relative Strength Index (14)
- 69.7
- 43.4
- Volatility (1 Year)
- 35.2%
- 80.1%
- Beta (5 Years)
- 0.52
- 1.07
MarginsIndustry
- Pretax Margin
- 40.2%
- -11.6%
- EBITDA Margin
- 42.7%
- -27.7%
Returns on capitalIndustry
- Return on Equity (ROE)
- 86.1%
- -49.9%
- Return on Assets (ROA)
- 21.0%
- -40.6%
Financial positionIndustry
- Current Ratio
- 1.39
- 3.30
- Quick Ratio
- 0.57
- 2.39
- Debt / Equity
- 1.23
- 0.49
- Debt / EBITDA
- 1.34
- 3.15
- Net Debt / EBITDA
- 1.21
- 1.97
GrowthIndustry
- Revenue Growth (YoY)
- 45.5%
- 6.82%
- Net Income Growth (YoY)
- 49.8%
- -14.4%
- EPS Growth (YoY)
- 50.7%
- -12.3%
- Revenue Growth (3Y CAGR)
- 31.7%
- 2.25%
- Revenue Growth (5Y CAGR)
- 21.6%
- 6.41%
- EPS Growth (3Y CAGR)
- 49.3%
- 1.30%
- EPS Growth (5Y CAGR)
- 27.6%
- 3.78%
EfficiencyIndustry
- Asset Turnover
- 0.66
- 0.40
- Inventory Turnover
- 0.93
- 2.73
- Revenue Per Employee
- $1.73M
- $429.29K
- Profits Per Employee
- $551.60K
- -$689.41K
- Employee Count
- 50,000
- 74
- WACC
- 7.63%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- $34.77B
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- -$44.62B
- $17.76M
- Net Cash Per Share
- -$47.43
- $0.80
- Equity (Book Value)
- $40.27B
- $53.89M
- Book Value Per Share
- $42.81
- $1.50
- Tangible Book Value
- $12.31B
- $27.13M
- Working Capital
- $18.27B
- $79.99M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- 2.03%
- -21.8%
- Dividend Yield
- 0.43%
- 1.88%
- Buyback Yield
- 0.43%
- -0.76%
- Shareholder Yield
- 0.86%
- 0.00%
- Dividend Per Share
- $6.23
- $0.83
- Dividend Growth (YoY)
- 15.4%
- 2.37%
- Years of Dividend Growth
- 9
- 0
- Payout Ratio
- 21.7%
- 55.4%
Taxes and interestIndustry
- Income Tax
- $7.19B
- $73.00K
- Effective Tax Rate
- 20.7%
- 20.9%
Scores and fair valueIndustry
- Graham Number
- $172.26
- $19.34
- Graham Upside
- -88.1%
- -46.6%
- Altman Z-Score
- 8.65
- 0.23
- Piotroski F-Score
- 7
- 4
- Beneish M-Score
- -1.85
- -2.63
- Lynch Fair Value
- $770.25
- –
- Lynch Upside
- -46.6%
- -28.9%
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | LLY | S&P 500 | Difference | LLY per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +23.7% | -3.0% | +26.8 pts | ||
| 3 months | +19.6% | -2.8% | +22.3 pts | ||
| Year to date | +35.0% | +11.5% | +23.5 pts | ||
| 1 year | +42.0% | +13.5% | +28.6 pts | ||
| 3 years | +140.5% | +77.7% | +62.8 pts | +34.0% | +21.1% |
| 5 years | +479.9% | +72.6% | +407.3 pts | +42.1% | +11.5% |
| 10 years | +2059.2% | +308.2% | +1751.1 pts | +36.0% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
7M LLY shares were sold short on Oct 30, 2026, up 3.6% from the previous report, or 0.86% of the shares available to trade. At recent volumes it would take 2.7 days to buy them back. Over the last 20 sessions, 36.0% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 7,213,927 | +3.6% | 2,709,288 | 2.7 |
| Oct 15, 2026 | 6,960,837 | -1.1% | 2,286,458 | 3.0 |
| Sep 30, 2026 | 7,035,434 | -6.4% | 2,400,203 | 2.9 |
| Sep 15, 2026 | 7,519,918 | -4.7% | 2,204,573 | 3.4 |
| Aug 31, 2026 | 7,894,476 | +20.3% | 2,640,226 | 3.0 |
| Aug 14, 2026 | 6,564,742 | -28.0% | 3,106,628 | 2.1 |
| Jul 31, 2026 | 9,117,184 | -11.3% | 2,316,357 | 3.9 |
| Jul 15, 2026 | 10,278,892 | +9.9% | 2,527,511 | 4.1 |
| Jun 30, 2026 | 9,353,153 | -3.2% | 3,624,842 | 2.6 |
| Jun 15, 2026 | 9,662,739 | -1.4% | 3,211,646 | 3.0 |
| May 29, 2026 | 9,795,475 | +16.2% | 3,307,630 | 3.0 |
| May 15, 2026 | 8,430,505 | +7.2% | 3,326,719 | 2.5 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?